CoChat

NADPH oxidase inhibitors: a patent review

Kim, Jung-Ae, Neupane, Ganesh Prasad, Lee, Eung Seok, Jeong, Byeong-Seon, Park, Byung Chul, Thapa, Pritam · 2011 · Expert Opinion on Therapeutic Patents
Cited by 69

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: NADPH oxidases, a family of multi-subunit enzyme complexes, catalyze the production of reactive oxygen species (ROS), which may contribute to the pathogenesis of a variety of diseases. In addition to the first NADPH oxidase found in phagocytes, four non-phagocytic NADPH oxidase isoforms have been identified, which all differ in their catalytic subunit (Nox1-5) and tissue distribution. AREAS COVERED: This paper provides a comprehensive review of the patent literature on NADPH oxidase inhibitors, small molecule Nox inhibitors, peptides and siRNAs. EXPERT OPINION: Since each member of the NADPH oxidase family has great potential as a therapeutic target, several different compounds have been registered as NADPH oxidase inhibitors in the patent literature. As yet, none have gone through clinical trials, and some have not completed preclinical trials, including safety and specificity evaluation. Recently, small molecule pyrazolopyridine and triazolopyrimidine derivatives have been submitted as potent NADPH oxidase inhibitors and reported as first-in-class inhibitors for idiopathic pulmonary fibrosis and acute stroke, respectively. Further clinical efficacy and safety data are warranted to prove their actual clinical utility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1517/13543776.2011.584870

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 69

Metadata

Authors
Kim, J.-A., Neupane, G. P., Lee, E. S., Jeong, B.-S., Park, B. C., & Thapa, P.
Venue
Expert Opinion on Therapeutic Patents
Published
2011-05-10
Volume
21
Issue
8
Pages
1147-1158
ISSN
  • 1354-3776 (ISSN-L)
  • 1744-7674
OpenAlex
W2069151126
Cited by
69
References
20
FWCI
5.17
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NADPH oxidase inhibitors: a patent review. https://app.cochat.ai/papers/10.1517/13543776.2011.584870
The paper
Kim, J.-A., Neupane, G. P., Lee, E. S., Jeong, B.-S., Park, B. C., & Thapa, P. (2011). NADPH oxidase inhibitors: a patent review. Expert Opinion on Therapeutic Patents. https://doi.org/10.1517/13543776.2011.584870

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.